Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 and standard of care chemotherapy in preclinical mesothelioma model. Malignant mesothelioma is a rare cancer type caused mainly by asbestos exposure.
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 and standard of care chemotherapy in preclinical mesothelioma model. Malignant mesothelioma is a rare cancer type caused mainly by asbestos exposure.